Day One Biopharmaceuticals Inc (DAWN) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Day One Biopharmaceuticals Inc   (NASDAQ: DAWN)


Day One Biopharmaceuticals Inc 's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Day One Biopharmaceuticals Inc 's ROA in the fourth quarter of 2025?
Day One Biopharmaceuticals Inc recorded a cumulative net loss of $-193 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -37.47%.

However, within the Healthcare sector 552 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from 3989 to 4400.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change -12.92 % -14.56 % 29.04 % 62.95 % 54.53 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -193 -251 -138 -79 -70
Return On Assets (TTM) -37.47 % -46.91 % -24.84 % -15 % -14.61 %
DAWN's Total Ranking # 4400 # 3989 # 3681 # 3497 # 4026
Total Assets (TTM) in million 505 511 516 532 580
Seq. Total Assets Change -1.13 % -1.03 % -2.86 % -8.39 % -2.99 %
Seq. Net Income Change - - - - -

DAWN's 5 Years Annual ROA >> Back to DAWN Management Effectiveness >> Compare DAWN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 229
Sector # 553
Overall # 4362

Return On Assets Statistics
High Average Low
-10.63 %
-35.08 %
-53.31 %
(Sep 30 2024)   (Mar 31 2024)





Financial Statements
Day One Biopharmaceuticals Inc 's Assets $ 505 million DAWN's Balance sheet
Day One Biopharmaceuticals Inc 's Income $ -21 million Quarterly DAWN's Income Statement
DAWN's Income by Division See DAWN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -12.92 % 54.53 % 7.93 % 20.2 % -
Total Assets in million 505 580 375 348 289
Y / Y Net Income Change - - - - -
Net Income in million 2 -7 -189 -142 -73
Annual Return On Assets 0.39 % -1.23 % -50.31 % -40.87 % -25.14 %

DAWN's 5 Years Annual ROA >> Back to DAWN Management Effectiveness >> Compare DAWN ROA to its Competitors



Comment on DAWN's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 0.39 % compared to prior year, due to annual net income growth of % to $1.98 million, and due to decline of value in Day One Biopharmaceuticals Inc 's assets by -12.92 % to $505.26 million, compared to $505.26 a year before.


More Return On Assets Ratios
DAWN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DAWN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DAWN's Competitors
Subscribers only: Roa for Day One Biopharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for DAWN's Customers

You may also want to know
DAWN's Roi DAWN's Inventory Turnover Ratio DAWN's Growth Rates DAWN's Dividend Comparisons
DAWN's Profitability Ratios DAWN's Asset Turnover Ratio DAWN's Dividend Growth
DAWN's Roe DAWN's Valuation Ratios DAWN's Financial Strength Ratios DAWN's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA

Date modified: 2026-09-18T13:11:06+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.